Stay updated with breaking news from Examination Pilot Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DURHAM - EmitBio™, a Durham-based biotechnology company operating as a subsidiary of KNOW Bio, has been issued a new U.S. patent that protects the company's
.jpg)
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Water Tower Research has published a business update and overview with Ballard Power Systems (NASDAQ:BLDP) (TSE:BLDP) CFO Paul Dobson. Ballard’s vision is to deliver fuel cell power for a sustainable planet. Ballard’s zero-emission PEM fuel cells are enabling electrification of medium- and heavy-duty mobility, including buses, commercial trucks, trains, and marine vessels. The company has $1.3 billion of cash to deploy and is focused on ...
Deadlines After May 31, relief will be available to large entities on a case by case basis. Deadlines between March 27 and July 30, 2020 for restoring priority of certain applications are extended. Misc. September 17, 2020. Initial examination of applications for trademarks related to COVID-19 products or services may be advanced in certain circumstances. Handwritten signatures no longer required; Patents 4 Partnership programs has been launched, with a focus on COVID-19 related technologies; applications for patent term extensions may be submitted via EFS. April 14, 2021 – The USPT...
To embed, copy and paste the code into your website or blog: On April 15, 2021, the United States Patent and Trademark Office (“USPTO”) implemented the COVID-19 Prioritized Examination Pilot Program (“Pilot Program”) to fast-track ex parte appeals of products or processes subject to an applicable FDA approval for COVID-19 use. Generally, appeals to the Patent Trial and Appeal Board (PTAB) are taken up for decision in the order they are docketed, with an average of 13 months from the time the PTAB receives the appeal to the date of the final decision. For qualifying appeals, the PTAB h...
Thursday, April 15, 2021 As a companion to the COVID-19 Prioritized Examination Pilot Program and patent-related relief provided by the 2020 CARES Act, the United States Patent and Trademark Office (“USPTO”) recently announced a similar Fast-Track Appeals Pilot Program for patent applications claiming a process or product requiring FDA approval for COVID–19 use. In general, under 35 U.S.C. § 134, once an Applicant’s claims have been twice rejected, the Applicant has a right to appeal the Examiner’s decision to a panel of administrative patent judges on the Patent Tr...